Genmab A/S (GMAB) develops antibody therapeutics for the treatment of the cancer and other diseases. The company is based in Copenhagen, Denmark, comes under Healthcare – Biotechnology sector & trades as “GMAB” ticker at Nasdaq.
GMAB made an all time high at $49.07 & currently favors correcting lower the sequence up since 2013 low. It favors a corrective bounce as connector, which expect to fail below all time high to resume lower in proposed zigzag correction.
Since 2013, all time low of $2.80, it ended an impulse sequence at $49.07 high. It ended ((1)) at $23.55 high & placed ((2)) at $12.10 low as correction. Wave ((2)) was 0.5 Fibonacci retracement of ((1)). It placed ((3)) at $44.83 high as 1.618 Fibonacci extension of ((1)). It favored ended ((4)) at $30.10 low. Finally, it ended ((5)) at $49.07 high as wave I in the sequence started since 2013 low. Below there, it correcting lower in II in proposed zigzag structure.
Below wave I high, it placed ((A)) at $26.19 low. Above there, it favors higher in ((B)) connector, which ideally should fail below all time high to resume lower in ((C)) leg. Currently, it favors pullback in (B) leg before upside in (C) of ((B)). We like to buy the dips towards equal leg areas, when reached in ((C)) of II for at least 3 swing bounce or upside in wave III.
Elliottwave Forecast updates 1-hour charts four times a day & 4-hour charts once a day for all our 78 instruments. We do a daily live session where we guide our clients on the right side of the market. In addition, we have a chat room where our moderators will help you with any questions you have about what is happening in the market at the moment. You can try us for 14 days for only $9.99.Back